CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 202,638 enrolled
Drug / intervention
screening questionnaire administration +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00058032
NCT00058032N/ACompleted

United Kingdom Collaborative Trial Of Ovarian Cancer Screening

University College, London·interventional·Posted Apr 9, 2003·Updated Nov 19, 2020

In Brief

A clinical study evaluating screening questionnaire administration and annual screening for Ovarian Cancer. Completed, enrolled 202,638 participants.

Detailed Summary

RATIONALE: Screening tests may help doctors detect ovarian cancer early when the survival is much more encouraging. It is not yet known whether a CA125-based or ultrasound strategy is more effective in detecting ovarian cancer early thereby impacting on the mortality from the disease in postmenopausal women from the general population. PURPOSE: Randomized clinical trial to assess the impact of screening using a multimodal strategy using CA125 interpreted by the Risk of Ovarian Cancer Algorithm (ROCA) followed by transvaginal ultrasound as a second line test versus transvaginal ultrasound on mortality from the disease in postmenopausal women from the general population.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOvarian Cancer
Countries--

Timeline

N/ACompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 9, 2003
Enrollment StartApr 17, 2001
Primary CompletionSep 29, 2005
Study CompletionJun 30, 2020
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 23.2 years ago

Interventions

screening questionnaire administrationother

annual screeningprocedure